CA 19-9 Pancreatic Cancer Marker Test: Comprehensive Guide
Understanding the CA 19-9 Pancreatic Cancer Marker Test
The CA 19-9 Pancreatic Cancer Marker Test represents a significant advancement in pancreatic cancer management and monitoring. This specialized blood test measures the levels of carbohydrate antigen 19-9, a tumor marker that plays a crucial role in the detection and management of pancreatic cancer. While not intended as a standalone screening tool for the general population, it serves as an invaluable asset in the comprehensive care of patients with suspected or confirmed pancreatic malignancies.
What Does the CA 19-9 Test Measure?
The CA 19-9 test specifically detects and quantifies the carbohydrate antigen 19-9 protein in the bloodstream. This glycoprotein is produced by pancreatic cancer cells and certain other gastrointestinal malignancies. The test utilizes advanced Chemiluminescent Microparticle Immunoassay technology to provide precise measurements, enabling healthcare providers to:
- Monitor treatment response in diagnosed pancreatic cancer patients
- Detect potential cancer recurrence following treatment
- Assess disease progression and treatment effectiveness
- Aid in differential diagnosis when pancreatic cancer is suspected
Who Should Consider This Test?
The CA 19-9 test is particularly recommended for individuals experiencing symptoms that may indicate pancreatic concerns or those with specific risk factors:
Symptoms and Risk Factors
- Unexplained abdominal pain that radiates to the back
- Jaundice (yellowing of skin and eyes)
- Unexplained weight loss and appetite changes
- New-onset diabetes in adults
- Family history of pancreatic cancer
- Personal history of chronic pancreatitis
- Patients undergoing treatment for pancreatic cancer
- Individuals with genetic syndromes associated with increased pancreatic cancer risk
Clinical Benefits of CA 19-9 Testing
Undergoing the CA 19-9 Pancreatic Cancer Marker Test offers multiple clinical advantages:
Early Detection Support
While CA 19-9 is not a primary screening test, elevated levels can prompt further investigation and imaging studies, potentially leading to earlier diagnosis in symptomatic individuals.
Treatment Monitoring
The test provides objective data to assess how well pancreatic cancer treatments are working, allowing for timely adjustments to therapy plans.
Recurrence Surveillance
Regular monitoring helps detect cancer recurrence at the earliest possible stage, improving treatment options and outcomes.
Prognostic Information
CA 19-9 levels can provide valuable information about disease severity and potential treatment response.
Understanding Your Test Results
Interpreting CA 19-9 test results requires professional medical expertise, but here’s general guidance:
Normal Range
Normal CA 19-9 levels typically fall below 37 U/mL. However, interpretation must consider individual factors and clinical context.
Elevated Levels
Increased CA 19-9 levels may indicate:
- Pancreatic cancer
- Other gastrointestinal cancers
- Benign conditions like pancreatitis or gallstones
- Liver disease or bile duct obstruction
Important Considerations
CA 19-9 levels should always be interpreted alongside clinical symptoms, imaging studies, and other diagnostic tests. Some individuals naturally have higher baseline levels, and not all pancreatic cancers produce elevated CA 19-9.
Test Information and Pricing
| Test Name | Sample Type | Turnaround Time | Discount Price | Regular Price |
|---|---|---|---|---|
| CA 19-9 Pancreatic Cancer Marker Test | 2 mL serum from SST tube | Daily | $40 USD | $44 USD |
Pre-Test Instructions
Please provide a brief clinical history when scheduling your test. No special preparation is typically required, but follow any specific instructions from your healthcare provider.
Nationwide Accessibility
We have testing facilities across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to this important pancreatic cancer marker testing regardless of your location.
Take Action for Your Health
Early detection and monitoring are crucial in pancreatic cancer management. The CA 19-9 test provides valuable information that can support your healthcare journey. Don’t wait – take proactive steps toward better health monitoring today.
Book your CA 19-9 Pancreatic Cancer Marker Test now by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Our team is ready to assist you with convenient testing options and answer any questions you may have about this important health assessment.
